| Institutional implementation of clinical tumor profiling on an unselected cancer population LM Sholl, K Do, P Shivdasani, E Cerami, AM Dubuc, FC Kuo, EP Garcia, ... JCI insight 1 (19), 2016 | 378 | 2016 |
| Multicenter feasibility study of tumor molecular profiling to inform therapeutic decisions in advanced pediatric solid tumors: the individualized cancer therapy (iCat) study MH Harris, SG DuBois, JLG Bender, AR Kim, BD Crompton, E Parker, ... JAMA oncology 2 (5), 608-615, 2016 | 203 | 2016 |
| Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy AJ Church, ML Calicchio, V Nardi, A Skalova, A Pinto, DA Dillon, ... Modern Pathology 31 (3), 463-473, 2018 | 131 | 2018 |
| A somatic activating NRAS variant associated with kaposiform lymphangiomatosis SF Barclay, KW Inman, VL Luks, JB McIntyre, A Al-Ibraheemi, AJ Church, ... Genetics in Medicine 21 (7), 1517-1524, 2019 | 102 | 2019 |
| Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors SH Ramkissoon, P Bandopadhayay, J Hwang, LA Ramkissoon, ... Neuro-oncology 19 (7), 986-996, 2017 | 90 | 2017 |
| A combination CDK4/6 and IGF1R inhibitor strategy for Ewing sarcoma LM Guenther, NV Dharia, L Ross, A Conway, AL Robichaud, JL Catlett, ... Clinical Cancer Research 25 (4), 1343-1357, 2019 | 75 | 2019 |
| Spreading depression expands traumatic injury in neocortical brain slices AJ Church, RD Andrew Journal of neurotrauma 22 (2), 277-290, 2005 | 65 | 2005 |
| Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study AA Ghazani, NM Oliver, JP St Pierre, A Garofalo, IR Rainville, E Hiller, ... Genetics in Medicine 19 (7), 787-795, 2017 | 57 | 2017 |
| Integrated genetic and pharmacologic interrogation of rare cancers AL Hong, YY Tseng, GS Cowley, O Jonas, JH Cheah, BD Kynnap, ... Nature communications 7 (1), 11987, 2016 | 53 | 2016 |
| Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma S Tannenbaum-Dvir, JLG Bender, AJ Church, KA Janeway, MH Harris, ... Molecular Case Studies 1 (1), a000471, 2015 | 48 | 2015 |
| Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms JL Davis, SO Vargas, ER Rudzinski, JM López Marti, K Janeway, ... Histopathology 76 (7), 1032-1041, 2020 | 47 | 2020 |
| DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor J Kamihara, V Paulson, MA Breen, TW Laetsch, D Rakheja, DS Shulman, ... Modern Pathology 33 (10), 1910-1921, 2020 | 46 | 2020 |
| MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma RS Goswami, EG Atenafu, Y Xuan, L Waldron, PP Reis, T Sun, A Datti, ... Journal of clinical oncology 31 (23), 2903-2911, 2013 | 46 | 2013 |
| Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition AL Hong, YY Tseng, JA Wala, WJ Kim, BD Kynnap, MB Doshi, G Kugener, ... Elife 8, e44161, 2019 | 40 | 2019 |
| Recurrent and novel USP6 fusions in cranial fasciitis identified by targeted RNA sequencing VA Paulson, IA Stojanov, JK Wasman, T Restrepo, S Cano, J Plunkitt, ... Modern Pathology 33 (5), 775-780, 2020 | 37 | 2020 |
| Fibrolamellar carcinoma: an entity all its own AF O'Neill, AJ Church, AR Perez-Atayde, R Shaikh, KJ Marcus, K Vakili Current Problems in Cancer 45 (4), 100770, 2021 | 30 | 2021 |
| Genomic and immunologic characterization of INI1-deficient pediatric cancers SJ Forrest, A Al-Ibraheemi, D Doan, A Ward, CM Clinton, J Putra, ... Clinical Cancer Research 26 (12), 2882-2890, 2020 | 30 | 2020 |
| A Novel ALK Fusion in Pediatric Medullary Thyroid Carcinoma K Hillier, A Hughes, RC Shamberger, S Shusterman, AR Perez-Atayde, ... Thyroid 29 (11), 1704-1707, 2019 | 23 | 2019 |
| Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer AJ Church, LB Corson, PC Kao, A Imamovic-Tuco, D Reidy, D Doan, ... Nature medicine 28 (8), 1581-1589, 2022 | 20 | 2022 |
| PD-1 and PD-L1 expression in osteosarcoma: which specimen to evaluate? S Chen, LM Guenther, A Aronhalt, L Cardillo, KA Janeway, AJ Church Journal of Pediatric Hematology/Oncology 42 (8), 482-487, 2020 | 20 | 2020 |
Katherine JanewayDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
